Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Aakash Rana

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UAMS

Also affiliated: Duke University (2024); Baylor College of Medicine (2023); Novant Health (2024); Central Arkansas Veterans Healthcare System (2024–2026); Duke University Hospital (2024); Arkansas Department of Health (2025–2026)

Faculty Researcher

2 h-index 25 pubs 7 cited

Research Areas

Biomedical Subjects

  • Cardiac Catheterization
  • Humans
  • Mitral Valve
  • Mitral Valve Insufficiency
  • Pulmonary Veins
  • Echocardiography, Transesophageal
  • Heart Valve Prosthesis Implantation
  • Venous Thrombosis
  • Myxoma
  • Thrombosis
  • Aged
  • Female
  • Treatment Outcome
  • Contrast Media
  • Gadolinium

Links

ORCID

OverviewAI-generated summary

Aakash Rana's research focuses on cardiovascular conditions, with a particular emphasis on interventional cardiology and cardiac valve disease. His work has explored rare clinical presentations, such as cor triatriatum sinister in adulthood and late-onset thrombus formation related to left atrial appendage occlusion devices. Rana has also investigated pulmonary vein thrombosis following transcatheter edge-to-edge repair of the mitral valve. His recent publications include studies on the association between epicardial fat thickness and controlled attenuation parameters in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), as well as real-world cardiovascular outcomes of combined SGLT2 inhibitor and GLP1 receptor agonist therapy in individuals with type 2 diabetes. He has also contributed to discussions on sex differences in the diagnosis and management of cardiovascular disease.

Metrics

  • h-index: 2
  • Publications: 25
  • Citations: 7

Selected Publications

  • 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
    Journal of the American College of Cardiology DOI OpenAlex
  • 26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)
    Journal of the American College of Cardiology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

14 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Kirby Von Edwins University of Arkansas for Medical Sciences
Venous Thromboembolism Diagnosis and Management Medical Case Reports Cardiovascular Function and Risk Factors
Good match 4 shared topics
Kunal Sarkar University of Arkansas for Medical Sciences
Cardiac Valve Diseases and Treatments Medical Case Reports Cardiovascular Function and Risk Factors
Good match 4 shared topics
Sangeetha Gummalla University of Arkansas for Medical Sciences
Medical Case Reports Diet and metabolism studies Cardiovascular Function and Risk Factors
Good match 4 shared topics
Zahra Hassan University of Arkansas for Medical Sciences
Medical Case Reports Cardiovascular Function and Risk Factors Retrospective Studies
Good match 3 shared topics
Binita Sapkota University of Arkansas for Medical Sciences
Medical Case Reports Cardiovascular Function and Risk Factors Retrospective Studies
Good match 3 shared topics
Nafisa K. Dajani University of Arkansas for Medical Sciences
Medical Case Reports Diet and metabolism studies Cardiovascular Function and Risk Factors
Good match 4 shared topics